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Abstract. Amino acid:[carrier protein] ligases (aa:CP ligases) are newly discovered homologs of ami-
noacyl-tRNA synthetases (aaRS) which aminoacylate carrier proteins instead of tRNA. Activated amino 
acids are attached to prosthetic group of carrier proteins by thioester bond. Weak thioacylation activity 
was observed for many conventional aaRS. Therefore, different thiols were investigated as substrate ana-
logs for aa:CP ligases. Here we show that coenzyme A, dithiothreitol and cysteine are efficiently aminoa-
cylated by aa:CP ligases. The crystal structure of aa:CP ligase from Bradyrhizobium japonicum in com-
plex with coenzyme A was solved, and revealed that CoA, besides acting as the substrate analog of the 
carrier protein, also competes with ATP for binding to the active site. aa:CP ligases do not aminoacylate 
tRNA, although they remarkably resemble catalytic core of atypical seryl-tRNA synthetases (aSerRS) 
from methanogenic archaea. Since aa:CP ligases lack tRNA-binding domain, fusion proteins of aa:CP li-
gases and aSerRS tRNA-binding domain were prepared in attempt to restore tRNA aminoacylation activi-
ty. Although fusion proteins were able to bind tRNA through appended domain, tRNA could not substi-
tute carrier proteins in aminoacylation reaction. (doi: 10.5562/cca1818) 
Keywords: aminoacyl-tRNA synthetase, amino acid:[carrier protein] ligase, carrier protein, coenzyme A, 
seryl-tRNA synthetase, thioester, tRNA 
 
INTRODUCTION 
Aminoacyl-tRNA synthetases are ancient and universal 
enzymes that catalyze the transfer of amino acids onto 
the appropriate transfer RNAs (tRNAs), primarily for 
use by the ribosome in protein synthesis.1 Because of 
their essential roles in translation of genetic code, genes 
encoding aaRSs appeared when life began.2,3 This long 
evolutionary history allowed the development of many 
other functions carried out by aaRSs, beyond their ca-
nonical role in protein biosynthesis.  
The tRNA aminoacylation reaction catalyzed by 
canonical aaRSs proceeds in two steps. The amino acid 
(aa) is first activated at the expense of ATP, to form 
aminoacyl-adenylate (aa-AMP), which stays tightly 
bound to the enzyme, while inorganic pyrophosphate 
(PPi) is released:  
aa + ATP + aaRS → aaRS:aa-AMP + PPi  (1) 
The activated amino acid is then transferred from the 
adenylate to the 3'-end of the tRNA to form aminoacy-
lated tRNA (aa-tRNA), in the reaction that releases AMP: 
aaRS:aa-AMP + tRNA → aa-tRNA + AMP + aaRS  (2) 
In the absence of aaRSs, amino acid activation reaction 
occurs at rate of only ~8.3 × 10–9 mol–1 s–1 (Refs. 4, 5) 
and has higher activation energy barrier than any reac-
tion involved in translation of mRNA. Thus, the emer-
gence of simple amino acid activating enzymes was 
crucial event in the evolution of protein synthesis ma-
chinery. aaRS family very likely evolved from simpler 
polypeptide chains by progressive accumulation of 
additional modular domains to the catalytic core with 
amino acid binding ability, allowing development of 
multi-domain, multi-functional contemporary enzymes 
of remarkable catalytic activity and specificity. Modern 
aaRSs can be divided into two classes, each consisting 
of ~10 members.6 Although they developed from dif-
ferent ancestors, and consequently share very little 
structural similarity, these two aaRS groups emerged 
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simultaneously.7–9 In addition to two aaRS classes with 
housekeeping cellular functions, numerous gene dupli-
cation events have generated a broad group of proteins 
generally referred to as aaRS-like proteins. Some of 
them are homologous to the full-length aaRSs, although 
the majority represent molecules homologous with 
specific domain of aaRS, that may or may not carry out 
functions related to the aminoacylation of tRNA.  
Seryl-tRNA synthetases are the enzymes respon-
sible for the serylation of tRNASer isoacceptors. They 
belong to subclass IIa of aaRSs, together with alanyl-, 
prolyl-, threonyl-, glycyl-, and hystidyl-tRNA synthe-
tases. SerRSs can be further divided into two structural-
ly different groups: bacterial-type SerRSs function in a 
variety of archaeal, bacterial and eukaryotic organisms, 
whereas the methanogenic-type was found only in 
methanogenic archaea.10,11 All seryl-tRNA synthetases 
(SerRSs) are functional homodimers with a C-terminal 
active site domain typical for class II aaRSs and an N-
terminal domain that is responsible for tRNA bind-
ing.12–15 We have recently shown that methanogenic-
type SerRSs display several idiosyncratic structural 
features and exhibit a different mode of substrate rec-
ognition in comparison with bacterial-type SerRSs.15–17 
Full-length or truncated SerRS-like proteins, homolog-
ous to both types of housekeeping SerRSs have been 
identified. SerRSs significantly divergent from canoni-
cal bacterial SerRSs, were found in two antibiotic pro-
ducing Streptomyces species. In S. viridifaciens, the 
pathway-specific seryl-tRNA synthetase (VlmL) from 
valanimycin biosynthesis cluster catalyzes the forma-
tion of seryl-tRNA, from which the seryl residue is 
transferred to another substrate in the valanimycin 
biosynthetic pathway.18 A bacterial SerRS homolog 
(Alb10), which confers antibiotic resistance to the host 
cells, is encoded by the gene residing in a cluster re-
quired for albomycin synthesis in Streptomyces sp. 
strain ATCC 700974 (Ref 19). In both organisms 
housekeeping bacterial-type SerRS is encoded by the 
second serS gene at different genetic locus. A new 
seryl-tRNA synthetase-like protein (named SLIMP) 
with an essential mitochondrial function has been iden-
tified in insect.20 Although the exact mechanism of 
SLIMP action remains unclear, Guitart et al. found that 
lethal knock-out of SLIMP gene could be suppressed 
by supplementing insect diet with antioxidants, sug-
gesting a role of SLIMP in oxidative stress. This SerRS 
paralog has lost the ability to bind amino acid and ATP, 
but retained tRNA binding. In contrast, we have recent-
ly described and characterized a new class of truncated 
SerRS-like proteins, which activate selected amino 
acids, but are deprived of the tRNA-binding domain 
and thus they lack canonical tRNA aminoacylating 
activity.21 Their genes were identified in numerous 
bacterial genomes. Expressed shortened SerRS-like 
proteins, which are structurally related to the catalytic 
core of atypical methanogenic-type SerRS (aSerRS),21 
were shown to transfer several activated amino acids to 
the –SH of phosphopantetheine prosthetic group, cova-
lently attached to the carrier proteins of yet unknown 
function. Therefore, these new enzymes act as amino 
acid:[carrier protein] ligases (aa:CP ligases). These 
SerRS-like proteins preferentially utilize glycine or 
alanine instead of serine as substrates in carrier protein 
aminoacylation reaction, although the overall mechan-
ism of amino acid recognition and the architecture of 
the active site are largely preserved and resemble those 
in methanogenic-type SerRSs. Furthermore, it was 
shown that the amino acid recognition is relaxed and 
rather unspecific, in sharp contrast to exquisitely high 
specificity of conventional SerRS and aaRS in substrate 
recognition. In this work we explore the specificity of 
SerRS-like aa:CP ligases towards amino acid acceptors. 
Here we show that small molecular weight thiols, 
coenzyme A and dithiothreitol in particular, can substi-
tute carrier proteins in aminoacylation reaction cata-
lyzed by aa:CP ligases, but tRNA is not a substrate for 
aminoacylation even when the missing tRNA binding 
domain is appended to aa:CP ligases, to facilitate tRNA 
binding. 
 
EXPERIMENTAL 
Preparation of Enzymes and tRNA 
Three aSerRS homologs (aa:CP ligases Bll0957 and 
Bll6282 from Bradyrhizobium japonicum and aa:CP 
ligase Atu2573 from Agrobacterium tumefaciens) were 
expressed as recombinant proteins in Escherichia coli. 
The proteins were His-tagged at N-terminus and were 
purified by standard procedures on Ni-NTA agarose 
(Qiagen) as previously described.21 In-frame fusions of 
N-terminal tRNA binding domain from Methanosarcina 
barkeri SerRS and aa:CP ligase coding sequences were 
created by overlap PCR.21 PCR fragments coding for 
fusion proteins were cloned to pET28b, and N-terminal 
His-tagged fusion proteins were overexpressed and 
purified as described. Preparation of SerRS from E. 
coli22 and M. barkeri23 was described previously. 
Isolation of unfractioned tRNA from B. japoni-
cum and A. tumefaciens was performed by phenol ex-
traction and polyetilene-glycol precipitation. Crude 
unfractioned tRNA was deacylated and further purified 
by anion-exchange chromatography on DEAE-cellu-
lose, essentially as described.21,24 Preparations of un-
fractioned tRNA from A. tumefaciens contained 4.6% 
tRNASer and 8.8% tRNAAla isoacceptors, while B. japo-
nicum bulk tRNA contained 5.4% tRNASer and 9.4% 
tRNAGly, as determined by aminoacylation with E. coli 
SerRS and A. tumefaciens or B. japonicum protein 
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extracts. Unfractioned E. coli tRNA was purchased 
from Roche. 
 
ATP Hydrolysis Assay 
Thiol-dependent ATP hydrolysis was assayed at 30 °C in 
solution containing 50 mmol dm–3 TrisHCl (pH = 7.5), 
150 mmol dm–3 KCl, 0.2 mg ml–1 BSA, 5 mmol dm–3 
MgCl2, 50 µmol dm–3 [α-32P]-ATP, 1 mmol dm–3 Ala 
(Atu2573) or 4 mmol dm–3 Gly (Bll0957, Bll6282), 10 U/ml 
inorganic pyrophosphatase (NEB), 0.6‒1.2 µmol dm–3 en-
zyme and 5 mmol dm–3 of different thiols (DTT, CoA, Cys 
or homocysteine). The reaction was stopped by mixing 
2.5 µl of reaction mixture with 3.75 µl of solution con-
taining 1 g dm–3 SDS and 0.5 mol dm–3 sodium acetate 
(pH = 5.0). Radiolabeled products, [32P]-AMP and [32P]-
ATP, were separated on PEI-cellulose TLC plates (Sigma-
Aldrich) developed in 0.1 mol dm–3 ammonium acetate 
and 5% acetic acid. Dried TLC plates were exposed on an 
imaging plate overnight, scanned using the Typhoon Phos-
phorImager (GE Healthcare), and quantified using Image-
Quant 5.2 software (Molecular Dynamics). 
 
TLC Analysis of Thiol Aminoacylation  
Transfer of radiolabeled amino acids to CoA, DTT or Cys 
was monitored under similar conditions as described for 
ATP hydrolysis assay, except ATP and enzyme concen-
tration was 4 mmol dm–3 and 12.5 µmol dm–3, respective-
ly. [U-14C]-Ala (120 µmol dm–3) was used as the sub-
strate for Atu2573 and [U-14C]-Gly (200 µmol dm–3) 
was used as the substrate for Bll0957 and Bll6282. After 
30 minutes of incubation, reaction mixtures were spot-
ted directly to TLC plates. The products of CoA, DTT 
and Cys aminoacylation were separated by different 
TLC procedures. Reaction mixtures containing CoA 
were spotted to PEI-cellulose TLC plates (Sigma-
Aldrich) and the plates were developed in solution con-
taining 0.1 mol dm–3 ammonium acetate, 0.2 mol dm–3 
NaCl and 5% acetic acid. DTT aminoacylation was 
analyzed on microcrystalline cellulose TLC plates (Flu-
ka) developed with 2-propanol:formic acid:water 20:1:5 
as the mobile phase, while products of Cys aminoacyla-
tion were also analyzed on microcrystalline cellulose 
TLC plates but developed with different solvent system 
(butanol:acetic acid:water 4:1:1). Radiolabeled products 
were visualized using Typhoon PhosphorImager.  
 
Crystallization and Structure Determination of 
Bll0957:CoA Complex 
Crystals of aa:CP ligase Bll0957 from B. japonicum 
were grown in a hanging drop by equilibrating 1 µl of 
protein solution (21 mg ml–1) and 1 µl of reservoir solu-
tion (0.17 mol dm–3 ammonium acetate (pH = 4.6), 
0.085 mol dm–3 sodium acetate, PEG 4000 w = 25.5%, 
glycerol φ = 15%) as previously described.21 Obtained 
crystals were then soaked for 3–5 h in a reservoir solution 
supplemented with 50 mmol dm–3 CoA, 10 mmol dm–3 
Gly, 10 mmol dm–3 ATP and 30 mmol dm–3 MgCl2. 
Crystals were flash-frozen in liquid nitrogen, data was 
collected on in-house Xcalibur Nova R diffractometer 
(Oxford Diffraction), scaled and converted to structure 
factor intensities using Scala and Truncate, respectively, 
from the CCP4 program suite.25 Coot26 was used to 
model substrates into the active site and Phenix.refine27 
program for rigid body and restrained refinement. Data 
collection and refinement statistics are summarized in 
Table 1. The atomic coordinates and structure factors of 
Bll0957:CoA complex have been deposited in the Pro-
tein Data Bank (PDB ID code 3PZC). 
 
Inhibition of Amino Acid Activation by CoA 
Inhibition of amino acid activation by CoA was moni-
tored in ATP-pyrophosphate exchange assay.28 ATP-PPi 
exchange assay was performed at 30 °C in 100 mmol 
dm‒3 TrisHCl (pH = 7.5), 150 mmol dm–3 KCl, 
0.2 mg ml–1 BSA, 30 mmol dm–3 MgCl2, 400 µmol dm–3 
Gly, 1–2.5 µmol dm–3 enzyme, 4 mmol dm–3 ATP and 
1 mmol dm–3 [32P]-PPi or 0.2 mmol dm–3 ATP and 
0.05 mmol dm–3 [32P]-PPi, and varying concentrations of 
CoA (1–15 mmol dm–3). Reaction was quenched, prod-
ucts were separated on PEI-cellulose TLC plates devel-
Table 1. Data collection and refinement statistics for 
Bll0957:CoA complex 
Crystal  
Data collection  
Space group P 21 21 2 
Cell dimensions  
   a, b, c / Å 128.19, 101.79, 50.62
 /  90, 90, 90  
Resolution  / Å 20.86–2.20 (2.32–2.20)*
Rmerge 0.075 (0.444) 
I / I 15.7 (2.7) 
Completeness / % 99.8 (99.9) 
Redundancy 4.9 (3.2) 
Refinement 
 
Resolution / Å 20.86–2.20 
No. reflections 32 404 
Rwork / Rfree 0.1670/0.2228 
No. atoms 4 996 
   Protein 4 585 
   Ligand/ion 60/2 
   Water 322 
B-factors  
   Protein 20.78 
   Ligand/ion 35.00/23.95 
   Water 30.49 
R.m.s. deviations  
   Bond lengths / Å 0.007 
   Bond angles /  1.041 
 One crystal was used for data measurement. 
* Values in parentheses are for highest-resolution shell. 
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oped in 0.75 mol dm–3 KH2PO4 (pH = 3.5) and 4 mol dm–3 
urea and quantified by phosphorimaging, as described for 
ATP hydrolysis assay. 
 
tRNA Aminoacylation Assay 
Aminoacylation of tRNA was monitored by standard 
tRNA aminoacylation assay.28 Reaction was perform- 
ed at 30 °C in 50 mmol dm–3 TrisHCl (pH = 7.5), 
150 mmol dm–3 KCl, 0.4 mg ml–1 BSA, 15 mmol dm–3 
MgCl2, 5 mmol dm–3 ATP, 150 µmol dm–3 [U-14C]-Ala 
(Atu2573), [U-14C]-Gly (Bll0957, Bll6282) or [U-14C]-
Ser (M. barkeri and E. coli SerRS), 2 mg ml–1 of unfrac-
tioned tRNA and 2 µmol dm–3 aa:CP ligase or fusion 
protein. Control reactions contained 0.5 mg ml–1 pro- 
tein extract from A. tumefaciens or B. japonicum or 
0.2 µmol dm–3 M. barkeri SerRS. Reaction mixtures were 
spotted on 3MM Whatman paper-discs, aminoacylated 
tRNA was precipitated with cold trichloroacetic acid 
(100 g dm–3) and quantified by scintillation counting. 
 
RESULTS AND DISCUSSION 
Thiol Aminoacylation by aa:CP Ligases 
The cognate substrates of aa:CP ligases are dedicated 
carrier proteins (CPs) carrying phosphopantetheine 
prosthetic group.21 Activated amino acids are transferred 
to sulfhydryl group of prosthetic arm and therefore 
aa:CP ligases catalyze thioester synthesis instead of 
tRNA esterification. It is well documented that many 
class I29–32 and class II33,34 aaRS, including E. coli 
SerRS, can transfer amino acids to different small-
molecular weight thiols, using either aminoacyl-tRNA 
or aminoacyl-adenylate as a donor. This thiol acylation 
activity is weak and it was interpreted as remnant edit-
ing activity of ancient aaRSs,29–31 but also as a vestige 
from a thioester world in which ancestral aaRSs pro-
vided aminoacyl thioesters for noncoded peptide syn-
thesis.32,34 Given that aa:CP ligases are by default de-
voted to thioester synthesis, and since they show ob-
vious structural similarity to class II aaRS catalytic core, 
we wondered if small-molecular weight thiols could act 
as substrate analogs, i.e. amino acid acceptors, for aa:CP 
ligases. 
Coenzyme A, dithiothreitol, cysteine and homo-
cysteine were tested as substrates for aa:CP ligases 
Bll0957 and Bll6282 from B. japonicum and aa:CP 
ligase Atu2573 from A. tumefaciens. Thiol aminoacyla-
tion by aa:CP ligases was followed indirectly, by moni-
toring thiol-dependent ATP hydrolysis, indicative of 
catalytic turnover and concomitant thiol aminoacylation 
(Figure 1). Since aa:CP ligases Atu2573, Bll0957 and 
Bll6282 have different amino acid specificities21, thiol-
Figure 1. Thiol-dependent ATP hydrolysis by aa:CP ligases from Agrobacterium tumefaciens (Atu2573; panel A) and Bradyrhizo-
bium japonicum (Bll0957 and Bll6282; panels B and C). The enzymes were incubated in the presence of dithiotreithol (●), coenzyme
A (□) cysteine (×) or homocysteine (+). No significant hydrolysis of ATP was observed in the absence of thiols (○). 
Table 2. Apparent rate constants (kapp) for thiol-dependent 
ATP hydrolysis by aa:CP ligases Atu2573, Bll0957 and 
Bll6282. ATP hydrolysis was assayed in the presence of 
5 mmol dm–3 coenzyme A (CoA), dithiotreithol (DTT), cys-
teine and homocysteine (HomoCys). The values are reported 
as arithmetic mean ± standard error of mean (SEM). 
  kapp / 10–2 s–1  
 Atu2573 Bll0957 Bll6282 
CoA 2.1 ± 0.2 5.0 ± 0.4 0.26 ± 0.01 
DTT 1.7 ± 0.2 3.16 ± 0.05  2.0 ± 0.1 
Cys 0.15 ± 0.03 1.03 ± 0.03 1.31 ± 0.09 
HomoCys n. d. 0.212 ± 0.007 0.133 ± 0.005 
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dependent ATP hydrolysis was followed in the presence 
of optimal amino acid substrate for particular enzyme: 
alanine in the case of Atu2573 and glycine in the case of 
Bll0957 and Bll6282. Curiously, enzymes display dif-
ferent preferences for thiols (Figure 1 and Table 2) as 
well: DTT is a good substrate for all three aa:CP ligases 
tested, CoA is the preferred substrate for Bll0957, while 
Atu2573 aminoacylates DTT and CoA approximately 
equally well. Bll6282 poorly aminoacylates CoA. Cys is 
aminoacylated by Bll6282 and Bll0957, but it is a weak 
substrate for Atu2573. Homocysteine was inefficiently 
recognized by all three enzymes tested. Apparent rate 
constants (Table 2) are comparable to and even exceed 
catalytic constants for thiol aminoacylation by different 
aaRS (kcat = 0.2 – 1.8 × 10–2 s–1 for CoA34), as expected 
for enzymes optimized to catalyze thioester synthesis. 
Apparent rate constants (Table 2) for aa:CP ligase 
aminoacylation of preferred thiol are close to turnover 
numbers for cognate CP aminoacylation by aa:CP ligas-
es (kcat = 0.35 s–1 for Bll0957, 0.1 s–1 for Bll6282 and 
0.64 s–1 for Atu2573) 21; they are approximately only an 
order of magnitude lower than kcat in CP aminoacylation 
reaction. However, the apparent rate constants for thiol 
aminoacylation were measured under high substrate 
concentration (5 mmol dm–3), unobtainable with cognate 
CPs. When CPs and thiols were assayed under identical 
conditions and much lower substrate concentration 
(50 µmol dm–3), no enzymatic activity could be detected 
in the presence of the thiols. Therefore, small-molecular 
weight thiols act as substrate analogs of CPs, but only 
under high substrate concentration. 
The transfer of activated amino acids to different 
thiols was confirmed by TLC analysis of the reaction 
mixtures containing 14C-amino acids (Figure 2). Exami-
nation of TLC plates revealed that radiolabeled amino 
acids were converted into the new products in the pres-
ence of the enzymes and various thiols. Different TLC 
plates and solvent systems were used to separate prod-
ucts of CoA, DTT and Cys aminoacylation in Figure 2 
(see Experimental) and hence radiolabeled amino acids 
and their products have different mobility in Figure 2 
a−c. The observed pattern of 14C-amino acid transfor-
mation on TLC plates mirrors the substrate preferences 
of different enzymes observed in the ATP hydrolysis 
assay (Figure 1): [14C]-Gly is only partially converted in  
S-glycyl-CoA by Bll6282 (Figure 1c and Figure 2a). 
Bll0957 and Bll6282 convert [14C]-Gly into a new 
product (Figure 2c) in the presence of cysteine, but 
[14C]-Ala remains unmodified by Atu2573, as expected 
from negligible stimulation of ATP hydrolysis by cyste-
ine (Figure 1a). 
 
The Structure of Bll0957:CoA Complex 
aa:CP ligases and structurally related class II aaRSs ami-
noacylate fundamentally different macromolecular sub-
strates: carrier proteins and tRNA, respectively. Amino 
acids are attached to the phosphopantetheine prosthetic 
group of carrier proteins by thioester bond. Coenzyme A 
also possesses phosphopantetheine moiety in its structure 
(Figure 3a) and it is efficiently recognized by aa:CP li-
gase Bll0957. We have recently solved the crystal struc-
ture of Bll0957 in complex with AMP, ATP and glycyl-
adenylate analog.21 In order to gain the insight how the 
prosthetic group of carrier proteins is accommodated in 
aa:CP ligase active site, and to shed some light on the 
catalytic mechanism of thioester synthesis by aa:CP li-
gases, we prepared the Bll0957:CoA complex by soaking 
Bll0957 crystals in solution containing CoA. 
The two polypeptide chains in the asymmetric unit 
form a homodimer. The overall structure closely resem-
Figure 2. TLC analysis of thioester synthesis catalyzed by aa:CP ligases. In the presence of the coenzyme A (panel A), dithiotrei-
tol (panel B) and cysteine (panel C), radiolabeled amino acids were converted into the new products by aa:CP ligases Atu2573,
Bll0957 and Bll6282. [14C]-Ala was used as substrate for Atu2573 and [14C]-Gly for Bll0957 and Bll6282. The positions of radi-
olabeled amino acids and their products are indicated on the picture. In each case different TLC plates and solvent systems, opti-
mized for particular separation, were used (see Experimental). 
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bles the catalytic core domain of methanogenic-type 
SerRS,16 as noted in our previous work.21 It comprises all 
three class II aaRS conserved motifs and zinc-ion charac-
teristic for methanogenic-type SerRS. Binding of CoA 
molecule in the active site of Bll0957 (Figure 3b) caused 
no change in the overall structure (r.m.s.d. of Cα atoms 
between Bll0957:AMP and Bll0957:CoA is 0.26 Å). 
CoA molecule is bound only in one subunit of the homo-
dimer; which seems to be more disordered. The other 
active site is occupied with glycyl-adenylate, the natural 
reaction intermediate.  
Coenzyme A resides in the part of the active site 
usually occupied with adenylate moiety of ATP or gly-
cyl-adenylate. However, CoA binds to adenylate bind-
ing pocket in a notably different manner (Figure 3b and 
3c). Adenine ring of CoA is bound in an inverted orien-
tation compared to ATP.16,21 The orientation of CoA is 
also different from all to date known crystal structures 
of class II aaRS complexed with ATP or aminoacyl-
adenylate intermediates. Nevertheless, the stacking 
interactions between conserved residues Phe172 and 
Arg286 are still maintained. The adenine ring of CoA 
forms putative hydrogen bonds with the main chain of 
Leu169, and via water molecules, with Arg173 and 
Asp285. The ribose moiety of the CoA molecule is 
dislocated compared to ATP, pointing its 3'-phosphate 
group towards the zinc atom. The closest distance be-
tween CoA and zinc-ion is 5.8 Å. This phosphate group 
is surrounded with Ser253, Lys235, Asn255 and even 
Glu176 (that coordinates zinc-ion) through a water 
molecule. Diphosphate moiety of CoA adopts almost 
the same position as β- and γ- phosphates of ATP mole-
cule, making putative hydrogen bonds with Glu237 and 
arginines 159, 168 and 286. The pantetheine arm is 
completely disordered and could not be traced in the 
electron density maps indicating its high flexibility. 
Lack of strong interactions between the pantetheine 
moiety and the protein suggests that the recognition 
between Bll0957 and its carrier protein (i. e. natural 
macromolecular substrate) is not achieved through the 
protein-prosthetic group interactions but probably 
through protein-protein interactions. While most of the 
amino acid residues surrounding CoA are in the same 
position as in ATP binary structure, the side chain of 
Arg159 is oriented differently, pushing Glu161 side 
chain out from the active site. In the complex with ATP 
Arg159 is at hydrogen bond distance to α- and β-
phosphates while side chain of Glu161 is hydrogen 
bonded to amino group of adenine ring. 
The binding of CoA to aa:CP ligase Bll0957 in the 
absence of other substrates (ATP and amino acid) is 
dominated by interactions with nucleotide moiety of 
CoA instead of pantetheine arm. Pantetheine moiety of 
CoA was not resolved in the crystal structure, but it is 
clearly positioned away from the catalytic site. This 
suggests that the interaction with nucleotide moiety of 
CoA, differentiating CoA from genuine substrate (i. e. 
carrier protein), leads to misplacement of pantetheine 
moiety. 
 
Figure 3. The complex of aa:CP ligase Bll0957 and CoA and its
comparison to ATP complex. Panel A: schematic representation
of carrier protein, the natural substrate of aa:CP ligases, and
coenzyme A structure. The part of the CoA molecule visible in
the electron density map of Bll0957:CoA complex (panel B) is
colored blue. Panel B and C: CoA and ATP, respectively, bound
in the active site of aa:CP ligase Bll0957. The ligands are co-
lored yellow. Cyan sphere represents active site zinc ion. The
red sphere is the water molecule. For clarity, some of the active
site residues (e.g. Arg186) are not shown. 
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The structure of aa:CP ligase Bll0957 in complex 
with CoA did not provide insight in prosthetic group 
accommodation and recognition, but instead revealed 
unanticipated binding mode of CoA to adenylate bind-
ing pocket. The structure of Bll0957:CoA complex 
indicated that CoA, beside acting as CP substitute in 
aminoacylation reaction, can also act as ATP analog. 
 
CoA Inhibits Amino Acid Activation by aa:CP Ligase 
Bll0957 
To ascertain whether CoA could compete with ATP for 
binding to the active site, amino acid activation in ATP-
pyrophosphate exchange assay in the presence of CoA 
was investigated. ATP-PPi exchange assay monitors the 
first half of the overall aminoacylation reaction; amino 
acid activation for subsequent transfer of amino acid to 
appropriate acceptor. Formation of enzyme bound ami-
noacyl-adenylate intermediate results in incorporation of 
32P from PPi into ATP in the reverse reaction. CoA effi-
ciently inhibited amino acid activation (Figure 4), con-
firming that CoA can compete with ATP for adenylate 
binding pocket. As expected for competitive inhibition, 
the extent of inhibition was dependent of ATP concentra-
tion (Figure 4): CoA concentration leading to 50% inhi-
bition (IC50) was (5.0 ± 0.5) mmol dm–3 in the presence 
of 0.2 mmol dm–3 ATP and (23 ± 3) mmol dm–3 when 
the concentration of ATP was raised to 4 mmol dm–3. 
The same pattern of inhibition was observed with 
acetyl-coenzyme A, an analog of CoA incapable to 
accept activated amino acid, confirming that observed 
decrease of ATP-PPi exchange is not the result of com-
petition between PPi exchange and CoA aminoacylation 
reaction.  
 
tRNA Aminoacylation by aa:CP Ligases and Fusion 
Proteins with tRNA-Binding Domain 
An intriguing question is how aa:CP ligases emerged 
during evolution. They share ancestry with class II 
aaRS, atypical SerRS in particular, as evidenced by 
conserved signature motifs and common structural fea-
tures.21 The main difference is the lack of N-terminal 
domain in aa:CP ligases, which plays the role of tRNA-
binding domain in atypical SerRS. The aa:CP ligases 
might have evolved from modern aSerRS, by loss of 
tRNA binding domain and subsequent adaptation to a 
novel biological role - carrier protein aminoacylation. In 
that case, low level of residual tRNA acylation activity 
would be expected, and possibly tRNA aminoacylation 
activity could be restored by providing tRNA-binding 
domain in cis. It was demonstrated for AlaRS,35 
MetRS36 and SerRS37 that their catalytic domain devoid 
of tRNA-binding domain retains residual tRNA ami-
noacylation activity. On the other hand, aaRS are mod-
ular enzymes and it is generally accepted that modern 
aaRSs originated from primitive catalytic cores capable 
of amino acid activation by subsequent acquisition of 
additional domains, such as tRNA-binding and editing 
domains.9 Therefore, aa:CP ligases could have evolved 
from primordial class II aaRS catalytic core, before it 
acquired tRNA-binding domain and adopted tRNA 
aminoacylation activity. To explore these possibilities, 
we have challenged aa:CP ligases with various tRNA 
 
Figure 4. Inhibition of ATP-pyrophosphate exchange by 
coenzyme A. aa:CP ligase Bll0957 from Bradyrhizobium 
japonicum was incubated in the presence of 4 mmol dm–3 ATP 
and 1 mmol dm–3 pyrophosphate (□) or 0.2 mmol dm–3 ATP 
and 0.05 mmol dm–3 pyrophosphate (○) and various concen-
trations of CoA. Calculated values of CoA concentrations 
leading to 50% inhibition (IC50) are indicated on the graph. 
 
Figure 5. tRNA aminoacylation by aa:CP ligase Atu2573 from 
A. tumefaciens (black symbols) and its fusion protein with 
tRNA-binding domain from M. barkeri SerRS (N-Atu2573; 
gray symbols). The enzymes were assayed with unfractioned 
tRNA from A. tumefaciens (At tRNA; square symbols) and E. 
coli (Ec tRNA; round symbols) Triangles denote negative con-
trols (no tRNA added). White symbols designate positive con-
trols, tRNA aminoacylation by protein extract from A. tumefa-
ciens. Insert: magnified view of the same data, expanded on the 
y-axis. The same results were obtained with aa:CP ligases 
Bll0957 and Bll6282 from B. japonicum (not shown). 
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substrates, and we have constructed fusion proteins of 
aa:CP ligases with N-terminal tRNA-binding domain 
from M. barkeri SerRS, in attempt to reveal their poten-
tially cryptic tRNA acylation activity. 
tRNA aminoacylation by aa:CP ligases was tested 
with various tRNA substrates, but in spite of many efforts 
no tRNA acylation activity could be detected (Figure 5). 
Homologous tRNA isolated from native source (i.e. A. 
tumefaciens for Atu2573, B. japonicum for Bll0957 and 
Bll6282) and heterologous tRNA from E. coli were 
offered to each enzyme. Unfractioned tRNA was used, 
in order to provide to enzymes all the naturally occur-
ring tRNA isoacceptors. The tRNA isolated from A. 
tumefaciens and B. japonicum were efficiently aminoa-
cylated in control reactions with protein extract pre-
pared from the same organism, containing endogenous 
aaRSs, and also with purified E. coli SerRS, and thus 
they were competent substrates for aminoacylation 
reaction.  
Fusion proteins were composed of tRNA-binding 
domain from M. barkeri aSerRS fused to N-terminus of 
Atu2573, Bll0957 and Bll6282. It is noteworthy that the 
aa:CP ligases, exemplified by the crystal structure of 
Bll0957,21 bear striking structural similarity to M. bar-
keri aSerRS and even possess the idiosyncratic HTH 
motif required for proper positioning of tRNA-binding 
domain in M. barkeri aSerRS. Fusion proteins were 
catalytically active in terms of amino acid activation,  
as verified by the active-site titration assay,28 but they 
were still unable to transfer activated amino acid to 
tRNA (Figure 5). M. barkeri SerRS, however, efficient-
ly charges unfractioned tRNA from A. tumefaciens, B. 
japonicum and E. coli, in accordance with previous 
findings that aSerRS can aminoacylate tRNASer from all 
three domains of life.38 Since tRNA-binding domain 
from M. barkeri SerRS can easily capture heterologous 
bacterial tRNASer for charging by catalytic domain, the 
absence of aminoacylation activity of fusion proteins is 
not a consequence of cross-species barrier in tRNA 
recognition. To ascertain that the fusion proteins can 
capture tRNA by appendent tRNA-binding domain, 
formation of noncovalent protein:tRNA complexes was 
confirmed by electrophoretic mobility shift assay, al-
though M. barkeri SerRS complexes with heterologous 
bacterial tRNA appeared more stable than the complex-
es of fusion proteins with tRNA (data not shown). These 
findings strengthen the conclusion that tRNA-binding 
domain can efficiently bind heterologous bacterial 
tRNA, although tRNA recognition is optimal in the 
native structural context of M. barkeri SerRS. In con-
clusion, tRNA can not substitute CPs in aminoacylation 
reaction by aa:CP ligases, even when the enzymes are 
endowed with tRNA-binding domain. However, lack of 
tRNA aminoacylation might be not due to inefficient 
tRNA recognition, but rather caused by the chemical 
nature of the reaction. It is possible that the aa:CP ligase 
active site is optimized for thioester synthesis, in such an 
extent that it cannot utilize -OH nucleophile as acceptor 
of activated amino acid. In this respect, it would be intri-
guing to replace 2'- and 3'-OH group of tRNA 3' terminal 
adenosine with thiol group, in attempt to alleviate poten-
tial "chemical barrier" in tRNA aminoacylation.  
Appending of tRNA-binding domain to aa:CP li-
gases was insufficient to convert them to aminoacyl-
tRNA synthetases and presumed cryptic tRNA aminoa-
cylation activity could not be recuperated in fusion 
proteins. Although definitive proof is lacking, these 
findings favor the hypothesis that aa:CP ligases origi-
nated from ancient catalytic core capable of amino acid 
activation before it gained tRNA acylation activity and 
subsequently evolved into aaRS. This notion is further 
supported by relaxed amino acid specificity of aa:CP 
ligases, uncommon to contemporary aaRS. Thus, aa:CP 
ligases might represent a glimpse into the evolution of 
class II aaRS. 
In this line it is worth mentioning that aa:CP ligas-
es are not the only aaRS homologs which renounced 
tRNA aminoacylation. For example, MshC, a homolog 
of CysRS from Mycobacterium smegmatis transfers 
cysteine to carbohydrate precursor of mycothiol39 and 
recently described truncated homolog of LysRS40,41 
aminoacylates elongation factor P. However, these ho-
mologs probably evolved from modern form aaRS, 
since MshC possesses shortened form of tRNA antico-
don binding domain42 and has retained amino acid spe-
cificity for Cys, while elongation factor P mimics tRNA 
shape and negative charge and might be viewed as pro-
teinaceus imitation of tRNA.43 It was proposed that 
asparagine synthetases, homologs of AsnRS lacking 
anticodon binding domain catalyzing asparagine synthe-
sis, also originated in archaeal lineage from existing 
AspRS.44 In conclusion, the descendants of aaRS, once 
regarded as enzyme family faithfully devoted to tRNA 
aminoacylation and translation of genetic code, can 
transfer amino acids to surprisingly diverse acceptors of 
amino acids, ranging from inorganic ions (NH4+), small 
organic molecules (mycothiol precursors) to macromo-
lecules other than tRNA (CPs, elongation factor P). 
 
CONCLUSIONS 
aa:CP ligases can efficiently utilize CoA, DTT and Cys 
to a lesser extent as substrate analogs in aminoacylation 
reaction. The crystal structure of aa:CP ligase in com-
plex with CoA reveals unusual mode of binding in ATP 
binding site. Contrary to our expectations, tRNA cannot 
substitute cognate carrier proteins in aminoacylation. 
No residual tRNA acylation activity could be recovered 
in aa:CP ligases even when they are fused with tRNA-
binding domain which they originally lack. Therefore, 
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aa:CP ligases diverged from aaRS ancestors before they 
acquired tRNA aminoacylation activity, and probably 
never served aminoacyl-tRNA synthesis and genetic 
code translation. 
 
Coordinates. The atomic coordinates and structure 
factors of aa:CP ligase Bll0957 complexed with CoA 
have been deposited in the RCSB Protein Data Bank 
(www.pdb.org, PDB ID code 3pzc). 
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